NCT05199584 2026-03-05
A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations
Endeavor Biomedicines, Inc.
Phase 2 Completed
Clinical Trials
3 trialsNCT06679634 2025-04-03
Retinoblastoma Phase II Expanded Access Clinical Trial
Targeted Therapy Technologies, LLC
Phase 2 Recruiting
NCT04990271 2021-08-04
A Clinical Study on the Efficacy and Safety of VEC Intravenous Chemotherapy Combined With Conbercept Intravitreal Injection in the Treatment of Retinoblastoma
Chengdu Kanghong Biotech Co., Ltd.
Phase 2 Unknown